Tibet AIM Pharm. Inc. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 96.087 million compared to CNY 105.939 million a year ago. Operating income was CNY 2.430 million compared to CNY 7.300 million a year ago. Net income was CNY 5.968 million compared to CNY 6.567 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.03 a year ago.